Customer Success Story: Empo Health® Empowers Diabetic Patients with Captivate® EDC
About the Customer
Empo Health, Inc. is a healthcare technology company focused on
improving patient outcomes with novel in-home health monitoring
devices and connected services. The company has developed the
FDA-listed Empo® Footprint and HIPAA-compliant Empo® Remote
Health Link for monitoring diabetic foot complications. Empo was
incorporated in 2020 by MIT-and-Stanford-trained technical
founders, is based in the San Francisco Bay Area, and is supported
by VC investors, angel investors, and SBIR grants.
The company’s remote monitoring platform includes a
high-resolution imaging scale and a connected clinician review
service. Patients can capture daily images of their feet at home
while healthcare professionals review the data for early warning
signs of complications. This approach brings proactive diabetic
foot care directly into patients’ homes and has the potential to
prevent costly and life-changing medical outcomes
The Challenge
By implementing Captivate, Empo Health was able to replace
manual, paper-based workflows with a digital system that
provides real-time visibility into data entry and quality
The Solution
By implementing Captivate, Empo Health was able to replace
manual, paper-based workflows with a digital system that
provides real-time visibility into data entry and quality
The Results
By implementing Captivate, Empo Health was able to replace
manual, paper-based workflows with a digital system that
provides real-time visibility into data entry and quality
The Challenge: Making Clinical Research Accessible and Scalable
With more than 20 million Americans living with diabetic
neuropathy and at risk of foot ulcers, the need for preventive
monitoring is significant. As Empo Health prepared to launch
its first real-world registry study, the team faced a common
challenge for early-stage medical device companies: finding
a validated electronic data capture (EDC) system that was
affordable, fast to implement, and compliant with clinical and
regulatory requirements.
“We needed a digital system that was compliant, easy to use,
and within our budget,” said Emily Hu, Clinical Consultant at
Empo Health. Paper-based data collection was not a
sustainable option for a multi-site study. The company needed
a modern, secure solution that would reduce manual effort,
eliminate transcription errors, and provide real-time visibility
into study data.
The Solution: Captivate® and the Weidley’s Wish Program
“
“Captivate fills a critical gap for companies like ours,” added Khandelwal. “It is empowering us to advance medical innovation while staying focused on what matters most: helping patients live healthier, fuller lives.”
Co-Founder and CEO at Empo Health
Empo Health chose Captivate®, ClinCapture’s cloud-based EDC system, through the
Weidley’s Wish program. The initiative offers small and mission-driven organizations
affordable access to ClinCapture’s validated technology so they can conduct high-quality
clinical research. Captivate’s intuitive configuration tools, real-time reporting, and built-in
audit capabilities allowed Empo Health to deploy its study quickly and manage data across
all sites without needing a large data management team.
“Compared to paper, Captivate makes it effortless to track data quality, resolve queries, and
see what’s happening across all sites at any moment,” said Hu.
The Challenge: Making Clinical Research Accessible and Scalable
By implementing Captivate, Empo Health was able to replace
manual, paper-based workflows with a digital system that
provides real-time visibility into data entry and quality
“The second a site updates data, we can see it,” said Hu.
“That makes auditing easy, ensures accuracy, and gives us
confidence in the integrity of our registry.”
The shift to electronic data capture improved data integrity,
supported compliance, and accelerated the company’s
ability to demonstrate real-world outcomes to payers and
healthcare partners.
“We believe our technology can help providers prevent
countless amputations and reduce costs to the healthcare
system,” said Anuj Khandelwal, Co-Founder and CEO at
Empo Health. “Captivate allows us to prove that through
enabling scalable, high-quality clinical evidence.”
Looking Ahead
As Empo Health expands its research efforts, Captivate will remain a key part of its data
management strategy. Together, ClinCapture and Empo Health are showing how accessible
clinical technology can drive medical innovation and improve patient outcomes.
Learn more about how ClinCapture's Weidley's Wish program empowers innovators like Empo Health to conduct world-class research at a fraction of the cost.
Summary
For more than a decade, ClinCapture’s Captivate® platform has helped expand what’s possible in clinical research by simplifying the way they're conducted - enabling secure data selection, improving patient engagement and ease of participation, and regulatory compliance across the full study lifecycle. From life-saving therapies to innovations that improve quality of life, meaningful advancements have been achieved by equipping these tools. Trusted by both globally recognized organizations and smaller, equally driven research teams, Captivate removes the operational challenges that once made running clinical trials complex and resource-intensive. Captivate allows teams to focus on discovery rather than tedious data collection process'—so the knowledge they generate from running clinical trials can benefit patients and communities worldwide.
Captivate products used